Article content continued Last month, the company’s co-founder said it was in talks with Russia, Brazil, Chile and Saudi Arabia to conduct Phase 3 trials, which determine whether the vaccine actually protects people against COVID-19 infection. Back in Canada, “we are continuing to wait for the vaccine,” said Scott Halperin, the Dalhousie scientist heading Canada’s… Read More »
WICHITA, Kan. (KWCH) – The KU School of Medicine in Wichita is looking for participants in a clinical trial for a COVID-19 vaccine. To be eligible, you must be at least 18 years old. The trial starts in late August in Wichita. KU School of Medicine Center of Clinical Research Director Dr. Tiffany Schwasinger-Schmidt, one… Read More »
What your doctor is reading on Medscape.com: By Marcia Frellick July 31, 2020 — Physicians are the most likely group of healthcare professionals to get a COVID-19 vaccine when one is available, according to a new Medscape poll. More than 7000 healthcare professionals, including clinicians, medical students, and administrators, responded to the poll. US physicians who responded… Read More »
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, testifies before the Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Capitol Hill in Washington DC on June 30, 2020 in Washington, DC. Kevin Dietsch | AFP via Getty Images White House coronavirus advisor Dr. Anthony Fauci said Friday that… Read More »
Almost daily, President Trump and leaders worldwide say they are racing to develop a coronavirus vaccine, in perhaps the most urgent mission in the history of medical science. But the repeated assurances of near-miraculous speed are exacerbating a problem that has largely been overlooked and one that public health experts say must be addressed now:… Read More »
By Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool A laboratory analyst working on a vaccine for the coronavirusIsopix/Shutterstock Latest coronavirus news as of 5 pm on 10 July UK has opted out of advance purchase of coronavirus vaccine candidates with the EU The UK government has decided not… Read More »
CHICAGO (Reuters) – Merck & Co Inc (MRK.N), which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines. It also announced a partnership with privately held Ridgeback Biotherapeutics to develop an… Read More »